THOMAS DANIEL AICHER,OWEN BRENDAN WALLACE,LEONARD LARRY WINNEROSKI, JUNIOR,XU YANPING,PETER BIAGIO ANZEVENO,LI RENHUA,ALEXEI PAVLOVYCH KRASUTSKY,THOMAS EDWARD MABRY,ASHRAF SAEED,NANCY JUNE SNYDER,GREG
申请号：
MYPI 20084205
公开号：
MY148128A
申请日:
2007.04.05
申请国别(地区):
MY
年份:
2013
代理人:
摘要：
THE PRESENT INVENTION DISCLOSES NOVEL COMPOUNDS OF FORMULA 1: HAVING 11 β-HSD TYPE 1 ANTAGONIST ACTIVITY, AS WELL AS METHODS FOR PREPARING SUCH COMPOUNDS. IN ANOTHER EMBODIMENT, THE INVENTION DISCLOSES PHARMACEUTICAL COMPOSITIONS COMPRISING COMPOUNDS OF FORMULA 1, AS WELL AS METHODS OF USING THE COMPOUNDS AND COMPOSITIONS TO TREAT DIABETES, HYPERGLYCEMIA, OBESITY, HYPERTENSION, HYPERLIPIDEMIA, METABOLIC SYNDROME, AND OTHER CONDITIONS ASSOCIATED WITH 11β-HSD TYPE 1 ACTIVITY.
